Karla Esbona

1.3k total citations
20 papers, 797 citations indexed

About

Karla Esbona is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Karla Esbona has authored 20 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Karla Esbona's work include Inflammatory mediators and NSAID effects (4 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Estrogen and related hormone effects (3 papers). Karla Esbona is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers) and Estrogen and related hormone effects (3 papers). Karla Esbona collaborates with scholars based in United States, Mexico and China. Karla Esbona's co-authors include Lee G. Wilke, Zhanhai Li, Marion L. Greaser, Wei Guo, Justin J. Jeffery, Patricia J. Keely, Sandeep Saha, Joe T. Sharick, Melissa C. Skala and Christine M. Walsh and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Karla Esbona

20 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karla Esbona United States 13 327 238 228 117 116 20 797
Kasumi Tozawa Japan 10 375 1.1× 286 1.2× 182 0.8× 46 0.4× 125 1.1× 15 1.0k
Phyllis Wachsberger United States 18 683 2.1× 224 0.9× 331 1.5× 58 0.5× 127 1.1× 41 1.1k
Joshua C. Anderson United States 20 667 2.0× 253 1.1× 196 0.9× 38 0.3× 62 0.5× 64 1.1k
Qianshan Ding China 19 526 1.6× 193 0.8× 254 1.1× 26 0.2× 50 0.4× 42 870
M. Lafitte France 14 401 1.2× 146 0.6× 146 0.6× 116 1.0× 24 0.2× 28 723
Jakub Toczek United States 16 303 0.9× 113 0.5× 140 0.6× 88 0.8× 135 1.2× 33 842
Elizabeth Bruckheimer United States 19 587 1.8× 475 2.0× 300 1.3× 25 0.2× 107 0.9× 32 1.2k
Yuxi Zhu China 17 492 1.5× 304 1.3× 479 2.1× 23 0.2× 99 0.9× 45 965
Fernando Jose Garcia-Marques United States 17 618 1.9× 100 0.4× 149 0.7× 43 0.4× 50 0.4× 34 952
Yunfeng Yuan China 15 418 1.3× 112 0.5× 229 1.0× 32 0.3× 35 0.3× 32 769

Countries citing papers authored by Karla Esbona

Since Specialization
Citations

This map shows the geographic impact of Karla Esbona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla Esbona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla Esbona more than expected).

Fields of papers citing papers by Karla Esbona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla Esbona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla Esbona. The network helps show where Karla Esbona may publish in the future.

Co-authorship network of co-authors of Karla Esbona

This figure shows the co-authorship network connecting the top 25 collaborators of Karla Esbona. A scholar is included among the top collaborators of Karla Esbona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla Esbona. Karla Esbona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mørk, Cato, Karla Esbona, Kwangok P. Nickel, et al.. (2024). Evaluation of a Novel MET-Targeting Camelid-Derived Antibody in Head and Neck Cancer. Molecular Pharmaceutics. 21(12). 6376–6384. 1 indexed citations
2.
Lee, Moon Hee, Wei Huang, David F. Jarrard, et al.. (2024). Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery. Cancers. 16(3). 478–478. 1 indexed citations
3.
Papadas, Athanasios, Gauri Deb, Adam Officer, et al.. (2022). Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment. Cell Reports. 40(7). 111201–111201. 21 indexed citations
4.
Marsh, Ian R., Michelle Turek, Joseph J. Grudzinski, et al.. (2021). Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting. PLoS ONE. 16(8). e0255798–e0255798. 20 indexed citations
5.
Huang, Wei, et al.. (2020). Ki67 index and mitotic count: Correlation and variables affecting the accuracy of the quantification in endocrine/neuroendocrine tumors. Annals of Diagnostic Pathology. 48. 151586–151586. 14 indexed citations
6.
Sharick, Joe T., Christine M. Walsh, Carley M. Sprackling, et al.. (2020). Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment. Frontiers in Oncology. 10. 553–553. 96 indexed citations
7.
Singh, Ashok, Ryan A. Denu, Jamie M. Sperger, et al.. (2020). Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancer. Molecular Oncology. 14(8). 1898–1909. 12 indexed citations
8.
Wan, Jun, et al.. (2019). Mad1 destabilizes p53 by preventing PML from sequestering MDM2. Nature Communications. 10(1). 1540–1540. 24 indexed citations
9.
Wang, Yanping, Heather Hardin, Ying‐Hsia Chu, et al.. (2019). Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas. Endocrine Pathology. 30(4). 262–269. 15 indexed citations
10.
Sharick, Joe T., Justin J. Jeffery, Christine M. Walsh, et al.. (2019). Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids. Neoplasia. 21(6). 615–626. 54 indexed citations
11.
Esbona, Karla, Sandeep Saha, Menggang Yu, et al.. (2018). The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients. American Journal Of Pathology. 188(3). 559–573. 84 indexed citations
12.
Hooks, M. Stacy, et al.. (2018). Abstract P5-01-01: Personalized neoadjuvant treatment planning using optical metabolic imaging. Cancer Research. 78(4_Supplement). P5–1. 1 indexed citations
13.
14.
Esbona, Karla, David R. Inman, Sandeep Saha, et al.. (2016). COX-2 modulates mammary tumor progression in response to collagen density. Breast Cancer Research. 18(1). 35–35. 87 indexed citations
15.
Esbona, Karla, Sandeep Saha, Menggang Yu, et al.. (2016). Abstract 3927: The presence of COX-2 and tumor-associated macrophages as a prognostic marker for invasive breast carcinoma patients. Cancer Research. 76(14_Supplement). 3927–3927. 1 indexed citations
16.
Esbona, Karla, David R. Inman, Kevin W. Eliceiri, Lee G. Wilke, & Patricia J. Keely. (2013). Abstract 4960: COX-2 inhibition with celecoxib delays the progression of invasive mammary carcinoma in a murine model of collagen dense stroma.. Cancer Research. 73(8_Supplement). 4960–4960. 1 indexed citations
17.
Esbona, Karla, Zhanhai Li, & Lee G. Wilke. (2012). Intraoperative Imprint Cytology and Frozen Section Pathology for Margin Assessment in Breast Conservation Surgery: A Systematic Review. Annals of Surgical Oncology. 19(10). 3236–3245. 158 indexed citations
18.
Guo, Wei, et al.. (2010). Titin Diversity—Alternative Splicing Gone Wild. SHILAP Revista de lepidopterología. 2010. 1–8. 102 indexed citations
19.
Kato, Kaori, Dai Yamanouchi, Karla Esbona, et al.. (2009). Caspase-mediated protein kinase C-δ cleavage is necessary for apoptosis of vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 297(6). H2253–H2261. 47 indexed citations
20.
Greaser, Marion L., Chad M. Warren, Karla Esbona, et al.. (2008). Mutation that dramatically alters rat titin isoform expression and cardiomyocyte passive tension. Journal of Molecular and Cellular Cardiology. 44(6). 983–991. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kasumi Tozawa Breakdown of academic impact, for papers by Phyllis Wachsberger Breakdown of academic impact, for papers by Joshua C. Anderson Breakdown of academic impact, for papers by Qianshan Ding Breakdown of academic impact, for papers by M. Lafitte Breakdown of academic impact, for papers by Jakub Toczek Breakdown of academic impact, for papers by Elizabeth Bruckheimer Breakdown of academic impact, for papers by Yuxi Zhu Breakdown of academic impact, for papers by Fernando Jose Garcia-Marques Breakdown of academic impact, for papers by Yunfeng Yuan
Rankless by CCL
2026